|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 801 to 900 out of 929 for Alk

0.041s

Categories

Hits by Pathway

Hits by Strain

Hits by Category

Type Details Score
Strain
Attribute String: mutant stock, targeted mutation
Protein
Organism: Mus musculus/domesticus
Length: 501  
Fragment?: false
Allele
Name: anaplastic lymphoma kinase; endonuclease-mediated mutation 1, Shanghai Model Organisms Center
Allele Type: Endonuclease-mediated
Attribute String: Null/knockout
Publication
First Author: Zhang H
Year: 2014
Journal: Proc Natl Acad Sci U S A
Title: Deorphanization of the human leukocyte tyrosine kinase (LTK) receptor by a signaling screen of the extracellular proteome.
Volume: 111
Issue: 44
Pages: 15741-5
Protein
Organism: Mus musculus/domesticus
Length: 481  
Fragment?: false
Publication
First Author: Reshetnyak AV
Year: 2018
Journal: Proc Natl Acad Sci U S A
Title: Identification of a biologically active fragment of ALK and LTK-Ligand 2 (augmentor-α).
Volume: 115
Issue: 33
Pages: 8340-8345
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein
Organism: Mus musculus/domesticus
Length: 140  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 168  
Fragment?: false
Allele
Name: transgene insertion 5, Hiroaki Honda
Allele Type: Transgenic
Attribute String: Inserted expressed sequence
Allele
Name: transgene insertion 9, Hiroaki Honda
Allele Type: Transgenic
Attribute String: Inserted expressed sequence
Allele
Name: collagen, type I, alpha 1; targeted mutation 1, Kwok-Kin Wong
Allele Type: Targeted
Attribute String: Humanized sequence, Inducible, Inserted expressed sequence
DO Term
Strain
Attribute String: mutant strain, coisogenic, transgenic
Strain
Attribute String: mutant strain, coisogenic, transgenic
Publication
First Author: Chen Z
Year: 2010
Journal: Cancer Res
Title: Inhibition of ALK, PI3K/MEK, and HSP90 in murine lung adenocarcinoma induced by EML4-ALK fusion oncogene.
Volume: 70
Issue: 23
Pages: 9827-36
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein
Organism: Mus musculus/domesticus
Length: 2312  
Fragment?: false
Allele
Name: transgene insertion 2, Louis Chesler
Allele Type: Transgenic
Attribute String: Humanized sequence, Inserted expressed sequence
Allele
Name: transgene insertion 60, Johannes H Schulte
Allele Type: Transgenic
Attribute String: Conditional ready, Inserted expressed sequence, Reporter
Allele
Name: anaplastic lymphoma kinase; targeted mutation 1, Stephan W Morris
Allele Type: Targeted
Attribute String: Null/knockout
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein
Organism: Mus musculus/domesticus
Length: 1100  
Fragment?: false
Genotype
Symbol: Alk/Alk
Background: involves: 129P2/OlaHsd * C57BL/6J
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Alk/Alk
Background: involves: 129P2/OlaHsd
Zygosity: hm
Has Mutant Allele: true
Allele
Name: anaplastic lymphoma kinase; targeted mutation 1.1, Hideki Enomoto
Allele Type: Targeted
Attribute String: Conditional ready, Humanized sequence, Inserted expressed sequence
Genotype
Symbol: Col1a1/Col1a1<+> Tg(Scgb1a1-rtTA)1Jaw/?
Background: involves: 129 * C57BL/6
Zygosity: cx
Has Mutant Allele: true
Genotype
Symbol: Alk/Alk Ltk/Ltk
Background: involves: 129 * 129P2/OlaHsd
Zygosity: cx
Has Mutant Allele: true
Publication
First Author: Bassermann F
Year: 2005
Journal: Cell
Title: NIPA defines an SCF-type mammalian E3 ligase that regulates mitotic entry.
Volume: 122
Issue: 1
Pages: 45-57
Protein Domain
Type: Domain
Description: This entry contains Nuclear-interacting partner of ALK (NIPA) and NIPA like proteins, as well as mRNA export factor Rsm1, all of which contain a C3HC-type zinc finger. The domain represented in this entry is found C-terminal to the zinc-finger like domain . Rsm1 is involved in mRNA export from the nucleus []. NIPA is an essential component of an SCF-type E3 ligase complex, SCF(NIPA), a complex that controls mitotic entry by mediating ubiquitination and subsequent degradation of cyclin B1 (CCNB1). Its cell-cycle-dependent phosphorylation regulates the assembly of the SCF(NIPA) complex, restricting CCNB1 ubiquitination activity to interphase. Its inactivation results in nuclear accumulation of CCNB1 in interphase and premature mitotic entry [].
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein
Organism: Mus musculus/domesticus
Length: 1233  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 428  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 770  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 595  
Fragment?: false
Publication
First Author: Cohen MA
Year: 2020
Journal: Cell Stem Cell
Title: Formation of Human Neuroblastoma in Mouse-Human Neural Crest Chimeras.
Volume: 26
Issue: 4
Pages: 579-592.e6
Genotype
Symbol: Tg(Th-ALK*F1174L)2Loch/? Tg(Th-MYCN)41Waw/?
Background: involves: 129X1/SvJ * BALB/c * C57BL/6J * CBA
Zygosity: cx
Has Mutant Allele: true
Genotype
Symbol: Tg(CAG-Alk*F1174L,-luc)60Jhsc/? Tg(Dbh-icre)1Gsc/?
Background: involves: C57BL/6 * FVB/N
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Tg(CAG-Alk*F1174L,-luc)60Jhsc/? Th/Th<+>
Background: involves: 129X1/SvJ * C57BL/6 * FVB/N
Zygosity: cn
Has Mutant Allele: true
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein
Organism: Mus musculus/domesticus
Length: 488  
Fragment?: false
Genotype
Symbol: Tg(CAG-Alk*F1174L,-luc)60Jhsc/? Tg(Dbh-icre)1Gsc/? Tg(Th-MYCN)41Waw/?
Background: involves: 129X1/SvJ * BALB/c * C57BL/6 * C57BL/6J * FVB/N
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Alk/Alk
Background: involves: 129X1/SvJ * C57BL/6 * C57BL/6N * SJL
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Alk/Alk Tg(Mpz-cre)94Imeg/?
Background: involves: 129X1/SvJ * C57BL/6 * C57BL/6N * SJL
Zygosity: cn
Has Mutant Allele: true
Publication
First Author: Lastwika KJ
Year: 2016
Journal: Cancer Res
Title: Control of PD-L1 Expression by Oncogenic Activation of the AKT-mTOR Pathway in Non-Small Cell Lung Cancer.
Volume: 76
Issue: 2
Pages: 227-38
Publication
First Author: Chiarle R
Year: 2005
Journal: Nat Med
Title: Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target.
Volume: 11
Issue: 6
Pages: 623-9
Publication
First Author: Huang S
Year: 2012
Journal: Cell
Title: MED12 controls the response to multiple cancer drugs through regulation of TGF-β receptor signaling.
Volume: 151
Issue: 5
Pages: 937-50
Publication
First Author: Yanagisawa H
Year: 2010
Journal: Neurosci Res
Title: Pleiotrophin induces neurite outgrowth and up-regulates growth-associated protein (GAP)-43 mRNA through the ALK/GSK3beta/beta-catenin signaling in developing mouse neurons.
Volume: 66
Issue: 1
Pages: 111-6
Publication
First Author: Agrotis A
Year: 1996
Journal: Biochem Biophys Res Commun
Title: Vascular smooth muscle cells express multiple type I receptors for TGF-beta, activin, and bone morphogenetic proteins.
Volume: 219
Issue: 2
Pages: 613-8
Publication
First Author: Ardini E
Year: 2010
Journal: Cancer Lett
Title: Anaplastic Lymphoma Kinase: role in specific tumours, and development of small molecule inhibitors for cancer therapy.
Volume: 299
Issue: 2
Pages: 81-94
Publication
First Author: Mano H
Year: 2012
Journal: Cancer Discov
Title: ALKoma: a cancer subtype with a shared target.
Volume: 2
Issue: 6
Pages: 495-502
Publication
First Author: Tucker ER
Year: 2015
Journal: Cancer Res
Title: Tackling Crizotinib Resistance: The Pathway from Drug Discovery to the Pediatric Clinic.
Volume: 75
Issue: 14
Pages: 2770-4
Publication
First Author: Wong CO
Year: 2015
Journal: Cell Rep
Title: Diminished MTORC1-Dependent JNK Activation Underlies the Neurodevelopmental Defects Associated with Lysosomal Dysfunction.
Volume: 12
Issue: 12
Pages: 2009-20
Publication  
First Author: Giaccone G
Year: 2023
Journal: Semin Cancer Biol
Title: Current knowledge of small cell lung cancer transformation from non-small cell lung cancer.
Volume: 94
Pages: 1-10
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein
Organism: Mus musculus/domesticus
Length: 482  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 424  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 1064  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 1302  
Fragment?: false
Publication
First Author: Rusan M
Year: 2018
Journal: Cancer Discov
Title: Suppression of Adaptive Responses to Targeted Cancer Therapy by Transcriptional Repression.
Volume: 8
Issue: 1
Pages: 59-73
Genotype
Symbol: Alk/Alk Tmem163/Tmem163<+>
Background: involves: 129X1/SvJ * C57BL/6 * C57BL/6N * FVB/N * SJL
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Alk/Alk Tg(Mpz-cre)94Imeg/? Tg(Th-MYCN)41Waw/?
Background: involves: 129X1/SvJ * BALB/c * C57BL/6 * SJL
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Alk/Alk<+> Tg(Mpz-cre)94Imeg/? Tg(Th-MYCN)41Waw/?
Background: involves: 129X1/SvJ * BALB/c * C57BL/6 * SJL
Zygosity: cn
Has Mutant Allele: true
Publication
First Author: Hoareau-Aveilla C
Year: 2015
Journal: J Clin Invest
Title: Reversal of microRNA-150 silencing disadvantages crizotinib-resistant NPM-ALK(+) cell growth.
Volume: 125
Issue: 9
Pages: 3505-18
Publication
First Author: Giuriato S
Year: 2010
Journal: Blood
Title: Conditional TPM3-ALK and NPM-ALK transgenic mice develop reversible ALK-positive early B-cell lymphoma/leukemia.
Volume: 115
Issue: 20
Pages: 4061-70
Publication
First Author: Kreutmair S
Year: 2020
Journal: J Clin Invest
Title: Loss of the Fanconi anemia-associated protein NIPA causes bone marrow failure.
Volume: 130
Issue: 6
Pages: 2827-2844
Publication
First Author: Hill CR
Year: 2015
Journal: Dev Dyn
Title: Type III transforming growth factor beta receptor regulates vascular and osteoblast development during palatogenesis.
Volume: 244
Issue: 2
Pages: 122-33
Publication
First Author: Chiarle R
Year: 2003
Journal: Blood
Title: NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors.
Volume: 101
Issue: 5
Pages: 1919-27
Publication
First Author: Merkel O
Year: 2010
Journal: Proc Natl Acad Sci U S A
Title: Identification of differential and functionally active miRNAs in both anaplastic lymphoma kinase (ALK)+ and ALK- anaplastic large-cell lymphoma.
Volume: 107
Issue: 37
Pages: 16228-33
Publication  
First Author: Umapathy G
Year: 2017
Journal: Sci Signal
Title: MEK inhibitor trametinib does not prevent the growth of anaplastic lymphoma kinase (ALK)-addicted neuroblastomas.
Volume: 10
Issue: 507
Publication
First Author: Guillot N
Year: 2012
Journal: PLoS One
Title: BAMBI regulates angiogenesis and endothelial homeostasis through modulation of alternative TGFβ signaling.
Volume: 7
Issue: 6
Pages: e39406
Publication
First Author: Soda M
Year: 2008
Journal: Proc Natl Acad Sci U S A
Title: A mouse model for EML4-ALK-positive lung cancer.
Volume: 105
Issue: 50
Pages: 19893-7
Publication
First Author: Ambrogio C
Year: 2005
Journal: Blood
Title: p130Cas mediates the transforming properties of the anaplastic lymphoma kinase.
Volume: 106
Issue: 12
Pages: 3907-16
Publication
First Author: Dejean E
Year: 2011
Journal: Leukemia
Title: Hypoxia-microRNA-16 downregulation induces VEGF expression in anaplastic lymphoma kinase (ALK)-positive anaplastic large-cell lymphomas.
Volume: 25
Issue: 12
Pages: 1882-90
Publication
First Author: Maddalo D
Year: 2014
Journal: Nature
Title: In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system.
Volume: 516
Issue: 7531
Pages: 423-7
Publication
First Author: Davare MA
Year: 2015
Journal: Proc Natl Acad Sci U S A
Title: Structural insight into selectivity and resistance profiles of ROS1 tyrosine kinase inhibitors.
Volume: 112
Issue: 39
Pages: E5381-90
Publication
First Author: Hrustanovic G
Year: 2015
Journal: Nat Med
Title: RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK-positive lung cancer.
Volume: 21
Issue: 9
Pages: 1038-47
Publication
First Author: Choudhari R
Year: 2016
Journal: Blood
Title: Redundant and nonredundant roles for Cdc42 and Rac1 in lymphomas developed in NPM-ALK transgenic mice.
Volume: 127
Issue: 10
Pages: 1297-306
Publication
First Author: Lin JJ
Year: 2017
Journal: Cancer Discov
Title: Targeting ALK: Precision Medicine Takes on Drug Resistance.
Volume: 7
Issue: 2
Pages: 137-155
Publication
First Author: Ogura H
Year: 2017
Journal: Sci Rep
Title: TKI-addicted ROS1-rearranged cells are destined to survival or death by the intensity of ROS1 kinase activity.
Volume: 7
Issue: 1
Pages: 5519
Publication
First Author: Eleveld TF
Year: 2018
Journal: Cancer Res
Title: RAS-MAPK Pathway-Driven Tumor Progression Is Associated with Loss of CIC and Other Genomic Aberrations in Neuroblastoma.
Volume: 78
Issue: 21
Pages: 6297-6307
Publication
First Author: Nikitski AV
Year: 2018
Journal: Am J Pathol
Title: Mouse Model of Poorly Differentiated Thyroid Carcinoma Driven by STRN-ALK Fusion.
Volume: 188
Issue: 11
Pages: 2653-2661
Publication
First Author: Clarke M
Year: 2020
Journal: Cancer Discov
Title: Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes.
Volume: 10
Issue: 7
Pages: 942-963
Publication
First Author: Rydén M
Year: 1996
Journal: J Biol Chem
Title: A novel type I receptor serine-threonine kinase predominantly expressed in the adult central nervous system.
Volume: 271
Issue: 48
Pages: 30603-9
Publication  
First Author: Hanemaaijer ES
Year: 2021
Journal: Proc Natl Acad Sci U S A
Title: Single-cell atlas of developing murine adrenal gland reveals relation of Schwann cell precursor signature to neuroblastoma phenotype.
Volume: 118
Issue: 5
Publication
First Author: Ma L
Year: 2016
Journal: Transl Stroke Res
Title: Integrin β8 Deletion Enhances Vascular Dysplasia and Hemorrhage in the Brain of Adult Alk1 Heterozygous Mice.
Volume: 7
Issue: 6
Pages: 488-496
Publication
First Author: Huang JF
Year: 2019
Journal: Oncogene
Title: Genome-wide screening identifies oncofetal lncRNA Ptn-dt promoting the proliferation of hepatocellular carcinoma cells by regulating the Ptn receptor.
Volume: 38
Issue: 18
Pages: 3428-3445
Publication
First Author: Mastini C
Year: 2023
Journal: Sci Transl Med
Title: Targeting CCR7-PI3Kγ overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphoma.
Volume: 15
Issue: 702
Pages: eabo3826
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein
Organism: Mus musculus/domesticus
Length: 2412  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 722  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 1068  
Fragment?: false